GX-101 program

N/A

Report date: 2025/03/20 16:13:16

Base Information

Drug NameGX-101 program

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsLupus Erythematosus, Systemic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGenovax SRL

China Registration ClassN/A

Develop Information

Active CompaniesGenovax SRL

Inactive CompaniesN/A

Active IndicationsLupus Erythematosus, Systemic

Inactive IndicationsN/A

Other Information

ATC CodeN/A